SEC Company Response from BioPharmX Corp (CIK 0001504167) — Aug 3, 2022

BioPharmX Corp (CIK 0001504167)
Date: Aug. 3, 2022 · CIK: 0001504167 · Accession: 0001104659-22-085511

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-265974

Date

August 4, 2022

Author

H.C. WAINWRIGHT & CO., LLC

Form

CORRESP

Company

BioPharmX Corp (CIK 0001504167)

Letter

Re: Timber Pharmaceuticals, Inc.

August 3, 2022

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

Registration Statement on Form S-1 (Registration No. 333-265974) - Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (333-265974) (the “Registration Statement”), hereby concurs in the request by Timber Pharmaceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. (Eastern Time), or as soon as practicable thereafter, on August 4, 2022, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text

CORRESP
1
filename1.htm

August
3, 2022

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

    Re:
    Timber Pharmaceuticals, Inc.

    Registration Statement on Form S-1 (Registration
    No. 333-265974) - Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright &
Co., LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration
statement on Form S-1 (333-265974) (the “Registration Statement”), hereby concurs in the request by Timber Pharmaceuticals, Inc.
that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. (Eastern Time), or as soon as
practicable thereafter, on August 4, 2022, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware
of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

    Very truly yours,

    H.C. WAINWRIGHT & CO., LLC

    By:
    /s/ Edward D. Silvera

    Name: Edward D. Silvera

    Title: Chief Operating Officer

430 Park Avenue | New York,
NY 10022 | 212.356.0500 | www.hcwco.com

Member: FINRA/SIPC

SecProbe.io